Margaret Kiss

Margaret Kiss has worked in a variety of roles in the scientific field. Margaret began their career in 2003 as a Post-doctoral fellow at Yale University School of Medicine. In 2007, they moved to RainDance Technologies as a Senior Research Scientist. Margaret then worked at Affomix Corporation as a Research Scientist from 2008 to 2010. In 2010, Kiss took a position as a Scientific Manager at Illumina. In 2011, they became the Director of Molecular Sciences at AxioMx, Inc., which was acquired by Abcam, Inc. in 2015. Currently, Kiss is the Director of R&D and Head of Immunoassay Development at Ancera.

Margaret Kiss earned their Bachelor of Arts in Biology from Cornell University between 1993 and 1997. Margaret then went on to pursue a Ph.D. in Genetics at Yale University, which they completed in 2003.